Sanofi | SAN - Cash And Equivalent


Sanofi reported EUR7.66B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
AbbVie USD 9.39B 4.16B Mar/2026
Aena EUR 2.05B 1.1B Dec/2025
Alcon AG USD 1.58B 80M Mar/2026
Almirall EUR 337.77M 14.83M Dec/2025
Amarin USD 131.06M 3.6M Mar/2026
Amgen USD 12.04B 2.91B Mar/2026
AstraZeneca USD 7.56B 1.85B Mar/2026
Bayer EUR 6.67B 774M Dec/2025
Biogen USD 3.38B 374.2M Mar/2026
BMW EUR 18.85B 2.83B Dec/2025
Bristol-Myers Squibb USD 9.57B 635M Mar/2026
Eli Lilly USD 5.28B 1.99B Mar/2026
Essilor EUR 3.54B 758M Dec/2025
Fresenius EUR 1.31B 81M Dec/2025
Fresenius Medical Care EUR 1.24B 343.37M Mar/2026
Genmab DKK 1.72B 46M Dec/2025
Gilead Sciences USD 7.56B 234M Dec/2025
GlaxoSmithKline GBP 3.44B 292M Mar/2026
GRIFOLS EUR 801M 242.31M Dec/2025
Hikma Pharmaceutical USD 236M 48M Jun/2025
J&J USD 21.69B 1.98B Mar/2026
Lakefront Biotherapeutics EUR 66.8M 21.06M Mar/2026
Lonza CHF 719M 188M Dec/2025
Mercedes-Benz AG EUR 12.25B 343M Dec/2025
Merck EUR 2.33B 77M Dec/2025
Merck USD 5.33B 9.24B Mar/2026
Novartis USD 6.88B 4.56B Mar/2026
Novo Nordisk A/S DKK 18.44B 5.78B Jun/2025
Orion EUR 160.9M 63.3M Dec/2025
Pfizer USD 1.7B 561M Mar/2026
Philips EUR 2.79B 882M Dec/2025
Recordati EUR 428.82M 42.64M Dec/2025
Regeneron Pharmaceuticals USD 2.96B 15.9B Mar/2026
Roche Holding CHF 7.55B 579M Jun/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sanofi EUR 5.54B 2.11B Mar/2026
SAP EUR 10.04B 1.83B Mar/2026
UCB EUR 1.57B 1.14B Dec/2024
Vinci EUR 17.25B 2.18B Dec/2025
Volkswagen EUR 38.8B 1.93B Dec/2025